Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 1/20 | 0.38 |
| ▸ | CCR5 | P51681 | 1/20 | 0.38 |
| ▸ | CCR8 | P51685 | 1/20 | 0.38 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.36 |
| ▸ | NOS3 | P29474 | 2/20 | 0.35 |
| ▸ | NOS1 | P29475 | 2/20 | 0.35 |
| ▸ | NOS2 | P35228 | 2/20 | 0.35 |
| ▸ | HASPIN | Q8TF76 | 1/20 | 0.35 |
| ▸ | ACVR2A | P27037 | 1/20 | 0.33 |
| ▸ | TGFBR2 | P37173 | 1/20 | 0.33 |
| ▸ | ABL1 | P00519 | 1/20 | 0.33 |
| ▸ | LOX | P28300 | 1/20 | 0.32 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.32 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.31 |
| ▸ | PLAU | P00749 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17471315 | 0.88 | LOX (0.46) | CCR1CCR5CCR8RIPK1KIF11 | |
| SCHEMBL18467784 | 0.79 | UHRF1 (0.46) | CCR1CCR5CCR8RIPK1KIF11 | |
| SCHEMBL19678810 | 0.79 | ASIC3 (0.38) | RIPK1NOS3NOS1NOS2ACVR2A | |
| SCHEMBL16231402 | 0.79 | UHRF1 (0.46) | CCR1CCR5CCR8NOS3NOS1 | |
| SCHEMBL14840716 | 0.78 | CCR1 (0.36) | CCR1CCR5CCR8RIPK1KIF11 | |
| SCHEMBL21105270 | 0.78 | LMNA (0.37) | CCR1CCR5CCR8RIPK1KIF11 | |
| SCHEMBL17471314 | 0.78 | NOS3 (0.38) | CCR1CCR5CCR8RIPK1KIF11 | |
| SCHEMBL14352975 | 0.78 | KDM4E (0.37) | ACVR2ATGFBR2LOXLOXL2NUDT1 | |
| SCHEMBL16230689 | 0.78 | KIF11 (0.35) | KIF11NOS3NOS2ACVR2ATGFBR2 | |
| SCHEMBL18372377 | 0.77 | CYP3A4 (0.46) | KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1298115-B1 | PROCESS FOR THE PREPARATION OF POLYHYDRIC ALCOHOLS | NAT INST OF ADVANCED IND SCIEN (JP) | 2009-08-26 | — | — | EP | disclosed |
| US-6656328-B2 | Subjecting a polyhydric alcohol compound having protected hydroxy group(s) to microwave irradiation in presence of basic compound or acid to deprotect the protecting groups of hydroxy group of polyhydric alcohol compound | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2003-12-02 | — | — | US | disclosed |
| EP-1298115-A1 | PROCESS FOR THE PREPARATION OF POLYHYDRIC ALCOHOLS | National Institute of Advanced Industrial Science and Technology (JP) | 2003-04-02 | — | — | EP | disclosed |
| US-20020157939-A1 | Process for preparation of polyhydric alcohols | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2002-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020157939-A1 | Process for preparation of polyhydric alcohols | ADH1C, ADH1A, ADH5 | CCR1 3420/4885CCR5 3126/4885CCR8 4021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.